[ASCO update 2006--highlights of the 42. meeting of the American Society of Clinical Oncology/ASCO 2006].
Currently, the treatment of gastrointestinal cancers is rapidly changing due to the implementation of novel chemotherapeutic agents as well as the introduction of targeted therapies into treatment protocols. The following review will give an overview on the most important clinical trials in esophageal, gastric, colorectal, pancreatic and hepatobiliary cancer that were presented at the annual meeting of the American Society of Clinical Oncology.
Reinacher-Schick
A
A
Medizinische Universitätsklinik, Knappschaftskrankenhaus, Ruhr-Universität Bochum.
Arnold
D
D
Lordick
F
F
Möhler
M
M
Lutz
M P
MP
Seufferlein
T
T
D002986:Clinical Trials as Topic; D005770:Gastrointestinal Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D008495:Medical Oncology / Q000379:methods* / Q000639:trends*; D014481:United States